Vancomycin- and erythromycin-induced hearing loss in humans
about
Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.Lack of effect of vancomycin and gentamicin on auditory function in guinea pigsPyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS.A clinical view of vancomycin in 1990.In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database reviewThe pharmacokinetic and pharmacodynamic properties of vancomycin.Understanding drug ototoxicity: molecular insights for prevention and clinical management.Vancomycin ototoxicity: a reevaluation in an era of increasing doses.Teicoplanin in perspective. A critical comparison with vancomycin.Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind.Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.Antimicrobial therapy for the elderly patient.Teicoplanin or vancomycin in the treatment of gram-positive infections?Vancomycin administration into the cerebrospinal fluid: a review.Erythromycin-induced hypoacusis: 11 new cases and literature review.Review on Usage of Vancomycin in Livestock and Humans: Maintaining Its Efficacy, Prevention of Resistance and Alternative Therapy.Sensorineural hearing loss associated with intrathecal vancomycin.Audiometric changes in patients undergoing liver transplantation using distinct immunosuppressive protocols.
P2860
Q30240026-E52E1C1D-50F4-4F80-987E-D86D25E6126CQ30532055-6CC4AE7E-E4D6-4173-A0E5-3F443EE171DFQ33379090-BC7E8AD7-A723-4C27-806E-A603DD6C6C79Q35643064-0E776641-7E7F-4826-B9C0-2A9A281FBBDDQ35812860-8E773AE7-F1F6-43A6-A5EF-7441288E51DDQ36290499-A82F4F8F-0474-47A8-AC83-00CE48FABEF8Q36328971-508EB10A-FA37-4FF5-8FF6-64556B46F97DQ36446895-C369AAD3-B2E0-49DA-8BCF-BC14E697961FQ37072057-2967FCF1-0A58-4079-BC68-1D0564242AA2Q37113420-F37749D7-9273-4E78-A079-BB856A8F97EAQ37771799-03446AE5-105E-4A1D-8193-EBCB6E3297F4Q37959271-8F1324E9-9926-4899-AB18-CDF73F0223DAQ38006505-5E2D8EB2-069A-4A9F-AC3B-400CA9DC130AQ40541603-CB7FA907-08B9-4045-B088-E0E1C7FF8F2DQ40842373-0C49EED8-9B4F-4D07-BEF0-3BF1F31C6E80Q40842382-FF5C05C4-FD5F-446C-8035-28C7ABAAD764Q43378543-CC598E6E-C1F7-4DCF-9E74-205B8922CD6EQ44263665-117E169E-740F-4F07-A92D-4959D17A0A4DQ46668970-E6F292B4-B2A8-4355-A481-3AEA9569970B
P2860
Vancomycin- and erythromycin-induced hearing loss in humans
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Vancomycin- and erythromycin-induced hearing loss in humans
@ast
Vancomycin- and erythromycin-induced hearing loss in humans
@en
type
label
Vancomycin- and erythromycin-induced hearing loss in humans
@ast
Vancomycin- and erythromycin-induced hearing loss in humans
@en
prefLabel
Vancomycin- and erythromycin-induced hearing loss in humans
@ast
Vancomycin- and erythromycin-induced hearing loss in humans
@en
P2860
P356
P1476
Vancomycin- and erythromycin-induced hearing loss in humans
@en
P2093
P2860
P304
P356
10.1128/AAC.33.6.791
P407
P577
1989-06-01T00:00:00Z